This global pharmaceutical giant continues to buy back shares and boost dividends.
These large caps have each taken steps to boost their long-term growth prospects.
This leading automaker should benefit from pent-up consumer demand, the rising age of cars on the road, and the introduction of new models.
With a royalty-based business model, this company offers upside exposure to gold without the risks of an individual mining outfit.
An FDA advisory board voted unanimously to approve sofosbuvir, leading to expectations that the treatment could soon get federal clearance.
With a 7 percent dividend yield and an undervalued stock, this asset management firm has begun a major turnaround.
Despite its strong stock price gains, this firm remains a favorite way to invest in Internet and mobile growth.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
The company is planning a 10-for-1 split, which will cut its share price dramatically.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
The start of a new year is a great time to reconsider key financial objectives.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.